Our study highlighted the role of SNHG14 in PD pathogenesis, and emphasized its regulatory relationship with SP-1 and miR-133b, providing significant theoretical foundation for developing novel therapies for PD and other neurodegenerative disorders. This evidence concerns the gene SP1 and Parkinson disease.